MBBS Honours: Obstetrics & Gynaecology	London	June 1988
Primary FRCS	London & Edinburgh	February 1990
Final FRCS	London	February 1993
FRCS Urol.		November 1996
Master of Surgery thesis	London	August 1994

1988	David Williams Prize in Obstetrics and Gynaecology
1989	SIMPLA Research Prize
1991	Research Fellowship from the Research Committee of St Thomas' Hospital
1995	Wessex Urological Group Prize
1996	Professor Chisholm Communication Prize, RSM
1996	Keith Yeates Gold Medal, FRCS Urol. Examination
1997	Royal College of Surgeons Traveling Fellowship
2005	Karl Stortz Gold Telescope Award

Jan 2005 Professor of UROLOGY Visiting Chair at the Prost Graduate Medical School of the Univesity of Surrey Guildford, Surrey

April 1998 Consultant Urological Surgeon Royal Surrey County Hospital, Guildford & Frimley Park Hospital, Frimley

August 1988 - HOUSE PHYSICIAN to
January 1989 Dr PI Reed, Dr RA Blackwood & Dr RDM Scott
Wexham Park Hospital, Slough, Berks

February 1989 - HOUSE SURGEON to
April 1989 Mr WF Hendry, Mr HN Whitfield, Mr RS Kirby
Dept. of Urology, St Bartholomew's Hospital, London

May 1989 - HOUSE SURGEON to
July 1989 Professor RFM Wood, Mr PA Lear, Mr RSK Phillips
Surgical Unit, St Bartholomew's Hospital, London

August 1989 - CASUALTY OFFICER to
January 1990 Dr DG Williams
Accident & Emergency Dept., St Thomas' Hospital, London

February 1990 - Demonstrator in Physiology
July 1990 United Medical and Dental Schools of
St Thomas' and Guy's Hospitals, London

April 1990 - HONORARY RESEARCH FELLOW
July 1991 Mr RW Lloyd-Davies, Mr MI Bultitude, Mr RC Tiptaft &
Mrs H Parkhouse
Dept. of Urology, St Thomas' Hospital, London

ST Bartholomew's Pre-Fellowship Surgical Rotation:
August 1991 - Orthopaedic SHO to
January 1992 Mr SC Chen, Mr PD Moynagh & Mr DL Grace
Chase Farm Hospital, Enfield, London

February 1992 - General Surgical SHO to
July 1992 Mr J Bolton
Chase Farm Hospital, Enfield, London

August 1992 - Urology SHO to
January 1993 Mr HN Whitfield, Mr WF Hendry & Mr RS Kirby
Dept. of Urology, St Bartholomew's Hospital, London

Post-Fellowship EXPERIENCE:
February 1993 - GENERAL SURGICAL JUNIOR REGISTRAR to
July 1993 Mr LJ Chalstrey & Mr WH Allum
St Bartholomew's Hospital, London

August 1993 - GENERAL SURGICAL REGISTRAR to
March 1994 Mr S Haynes & Mr AJ Goodman
Cheltenham General Hospital, Cheltenham

April 1994 - UROLOGY REGISTRAR to
October 1994 Mr RB Kinder & Mr G Suresh
Cheltenham General Hospital, Cheltenham

SOUTH & WEST R.H.A. SENIOR REGISTRAR ROTATION IN UROLOGY
April 1996 - UROLOGY SENIOR REGISTRAR to
March 1997 Mr RC Feneley, Mr AG Timoney, Mr JC Gingell, Mr P Abrams
& Mr DA Gillatt
Southmead Hospital, Bristol

November 1994 - UROLOGY SENIOR REGISTRAR to
March 1996 Mr CU Moisey & Mr C Gallegos
Royal United Hospital, Bath

Basic Surgical Techniques	Royal College of Surgeons	1991
ATLS course	St Bartholomew's Hospital	1993
BARD Urolase course	Epsom Hospital	1994
Andrology course	Institute of Urology, London	1995
Paediatric course	Cambridge	1995
Basic Science course	Institute of Urology, London	1995
Transplantation course	Oxford	1996
Spinal Injuries course	Sheffield	1996
S. & W. Management course	Bristol	1996
Brachytherapy course	Tampa, USA	1998
Brachytherapy course	Seattle, USA	1999
Consultant appraisal course	Royal College of Surgeons	2002
Management skills course	Southampton	2002
Teaching the teachers course	Royal College of Surgeons	2003

Hattersley A, Langley SEM, Blackwood R. Home intravenous diuretic therapy for patients with refractory heart failure. Lancet 25th February 1989.

Langley SEM, Graves J, Fry CH. Measurement of the ionic composition of urine with ion-selective electrodes. Journal of Physiology 1991 438:75.

Langley SEM & Fry CH Factors influencing the free Ca2+ in urine from normal subjects and patients with urinary tract stones. Journal of Physiology 1991 446: 584.

Langley SEM & Fry CH. A new method for measuring the calcium ion concentration directly in whole urine. Journal of Urology 1993 149: 442.

Langley SEM & Fry CH. The relationship between urinary Ca2+, pH and stone disease. In Urolithiasis. Ryall R & Marshall V. (eds) Plenum Publishing Corp, New York. 1995

Langley SEM & Fry CH. Differences in the free [Ca2+] in undiluted urine from stone formers and normal subjects using a new generation of ion-selective electrodes. British British Journal of Urology 1995 75(3): 288.

Langley SEM & Fry CH. The influence of pH on urinary ionised [Ca2+] - Differences between urinary tract stone formers and normal subjects. British Journal of Urology 1997 77(1): 12.

KTP laser bladder neck incision, BNI, with Nd:YAG ablation of the prostate reduces post-operative catheterization time. SPIE Proceedings 1997.

Langley SEM, Gallegos CRR, Moisey, CU. The evaluation of endoscopic Nd:YAG laser prostate ablation with or without KTP bladder neck incision by prospective randomized trial. British Journal of Urology 1997 80 (6): 880.

Langley SEM, Laing R. Prostate Brachytherapy has come of age: A review of the techniques and results. British Journal of Urology International 2002. 89(2) 1-14.

Henderson A, Cahill D, Laing RW Langley SEM. Iodine125 Prostate Brachytherapy: Selection strategies outcome from our first 100 consecutive patients. . British Journal of Urology International 2002. 90(6) 567-572.

J Shah, B Montgomery, SEM Langley, A Darzi, Validation of a flexible cystoscopy course. . British Journal of Urology International 2002. 90(9) 833-835.

Henderson A, Laing RW, Langley SEM. A spanner in the works; the use of a new temporary urethral stent to relieve bladder outflow obstruction following prostate brachytherapy. Brachytherapy 1(4) (In Press).

Henderson A, Laing RW, Langley SEM. Is Bicalutamide equivalent to goserelin for prostate volume reduction prior to prostate brachytherapy? Clinical Oncology 2003; 15: 318-321

Henderson A, Laing RW, Langley SEM.
Intraoperative identification of pubic arch interference in prostate brachytherapy: simplifying the transrectal ultrasound technique. Brachytherapy 2003; 2(4) 240-245

Bott S, Henderson A, Laing RW, Parkinson C, Langley SEM.
Setting up a prostate cancer database: how to get out more than you put in.
British Journal of Urology International 2003; 92(7) 665

Henderson A, Laing RW, Langley SEM.
Quality of Life following Treatment for Early Prostate Cancer : Does Brachytherapy offer a better quality of life?
European Urology 2004; 45 134-141

Henderson A, Laing RW, Langley SEM
Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores
British Journal of Urology International 2004; 93 (1), 180

Langley SEM, Henderson A, Laing RW.
The spirit of research: A new well funded randomised study comparing brachytherapy to radical prostatectomy is about to open in the UK
British Journal of Urology International 2004; 93(1), 6

Bott S, Henderson A, McLarty E, Langley SEM.
A brachytherapy template approach to standardize saturation prostatic biopsy.
British Journal of Urology International 2004; 93(4) 662

Henderson A, Ismail A, Cunningham M, Aldridge S, Loverock L, Langley SEM, Laing RW. Toxicity and early biochemical outcomes from 125Iodine prostate brachytherapy: a prospective study. Clinical Oncology 2004; 16(2) 95-104

Henderson A, Andrich DEA, Pietrasik ME, Higgins D, Montgomery B, Langley SEM. Outcome analysis and patient satisfaction following octant transrectal ultrasound-guided prostate biopsy: A prospective study comparing consultant urologist, specialist registrar and nurse practitioner in urology.
Prostate Cancer and Prostatic Diseases 2004; 7,122-125

Sooriakumaran P, Henderson A, Laing RW Langley SEM. Quality of life issues with prostate brachytherapy.
Urology, 2004 8(5) 12-17

Henderson A, Laing RW Langley SEM. Quality of life following treatment for early prostate cancer: Does low dose rate (LDR) brachytherapy offer a better outcome? A review.
European Urology 2004 45 134-141

Henderson A, Sooikumaran P, Langley SEM, Laing RW
Brachytherapy: The Surgeon’s Perspective
British Journal of Urology International 2004; 93(7):1118

Henderson A, Bott SRJ, Sooikumaran P, Laing RW, Langley SEM
Urinary Morbidity After 125Iodine Brachytherapy of the Prostate
British Journal of Urology International 2004; 93(6): 890

Langley SEM & Laing RW
Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer. Prostate Cancer and Prostate Diseases 2004; 7 201-207

Langley SEM, Laing RW, Henderson A, Aaltomaa S, Kataja V, Palmgren J-E, Bladou F, Salem N, Serment G, Nava L, Losa A, Guazzoni G, Guedea F, Aguilo F, Suarez JF. European Collaborative Group on Prostate Brachytherapy: Preliminary Report in 1175 Patients. European Urology 2004; 46(5) 565-570

Henderson A, Bott S, Sooriakumaran P, Laing RW, Langley SEM.
Brachytherapy, Urethral Dosimetry, and Urinary Symptoms
British Journal of Urology International 2004;93(6):890

Sooriakumaran P, Henderson A, Laing RW, Langley SEM.
Does Brachytherapy Offer a Better Quality of Life in the Management of Early Prostate Cancer?
Revista de Urologia July 2004 4 567-570

Henderson A, Sooriakumaran P, Laing RW, Langley SEM.
Quality of Life after Radical Treatments for Prostate Cancer
In: Prostate Cancer Research 2004 Vol 1, Novascience Publishers, New York

Publications in print

Henderson A, Laing RW, Langley SEM
Quality of life and voiding (dys)function after radical prostatectomy
British Journal of Urology International (In Press 2004, Publication Date Awaited

Publications Submitted

Garrett WV, Menezes N, Henderson A, Langley SEM and Bailey ME.
Total extra-peritoneal hernia repair should not compromise subsequent treatment of Prostate cancer. Submitted to British Journal of Surgery 2004

Bott SRJ, Halls JE, Henderson A, Laing RW, Montgomery BSI and Langley SEM.
Extensive transperitoneal template biopsies of the prostate – the technique and results. Submitted to European Urology 2004

Bott SRJ, Henderson A, Montgomery BSI and Langley SEM.
Prostate biopsy in the over 80s, crucial or cruel?
Submitted to British Journal of Urology International 2004

Books

Ion Selective Electrodes in Biological Systems, CH Fry & SEM Langley 2001
Harwood Academic Publishers

A patient's guide to prostate cancer.
Langley SEM 1999 & rewritten 2002

A patient’s guide to prostate brachytherapy
Langley SEM 2004

A patient’s guide to bladder cancer.
Langley SEM Montgomery BSI & Borwell J 2004

Book chapters

Henderson A, Sooikumaran P, Laing RW, Langley SEM.
Oncological and Quality of Life Outcomes of Brachytherapy and other treatments for EPC In Press in Prostate Cancer Research 2003 Vol I, Novascience NYNY

Recently published abstracts

Cahill D, Henderson A, Langley SEM, Laing RW. (Presented by Cahill D)
Prostate Brachytherapy: Patient Assessment and Symptomatic Response
British Association of Urological Surgeons-Dublin 2001
Abstracted to British Journal of Urology International 2001;88 (Supplement 1): 49

Henderson A, Cahill D, Langley SEM, Laing RW. Prostate Brachytherapy: A prospective analysis of urological symptoms. British Cancer Research Meeting-Leeds 2001.Abstracted to the British Journal Cancer 2001; 85(Supplement 1): 16

Henderson A, Cahill D, Laing RW, Langley SEM. Prostate Brachytherapy; lessons from our first 100 patients. European Association of Urologists, Annual Meeting, Birmingham 2002
Abstracted to European Urology 2002 1(Supplement 1) pp46

Henderson A, Laing RW, Langley SEM. Toxicity following Iodine125 prostate brachytherapy: prospective prediction of symptoms using urodynamics. European Society for Therapeutic Radiology and Oncology, Altalya Turkey, May 2002
Abstracted to Radiotherapy & Oncology 2002; 63(supplement 1): 48

Henderson A, Laing RW, Langley SEM. Iodine125 prostate brachytherapy: selection strategies and early outcome. British Association of Urological Surgeons-Glasgow 2002
Abstracted to British Journal of Urology International 2002;90(supplement 1):20(p118)

Henderson A, Laing RW, Langley SEM.
Cytoreduction for brachytherapy : Not all antiandrogens are equal
British Association of Urological Surgeons-Glasgow 2002
Abstracted to British Journal of Urology International 2002;90(supplement 1):68(p147)

Henderson A, Langley SEM, Laing RW. Iodine125 Prostate Brachytherapy – Early outcome, toxicity and patient selection – a prospective study. British Association of Surgical Oncology/ British Oncology Association-Cambridge 2002
Abstracted to Clinical Oncology 2002; 14(4);518(p47)

Henderson A, Langley SEM, Laing RW. Iodine 125 Prostate Brachytherapy – Early outcome, toxicity and patient selection – a prospective study. European Society of Therapeutic Radiation and Oncology, Prague 2002
Abstracted to Radiotherapy & Oncology 2002;64(supplement 1): 972(s286)

Henderson A, Laing RW, Langley SEM. A prospective study of urinary symptoms following 125Iodine seed brachytherapy: is urodynamics the essential test to determine risk of postoperative catheter use? European Association of Urologists, Annual Meeting, Madrid 2003
Abstracted to to European Urology 2003;2(1): pp134 (abstract 526)
Winner Best Poster In Session; Non-Surgical Treatment of Prostate Cancer

Henderson A, Andrich DEA, Pietrasik ME, Langley SEM
Outcome analysis of TRUS guided prostate biopsy: a prospective study comparing cancer detection between consultant urologist, specialist registrar and nurse specialist in oncology. European Association of Urologists, Annual Meeting, Madrid 2003
Abstracted to European Urology 2003;2(1): pp109 (abstract 427)
Winner Best Poster In Session; Biopsy and Detection of Prostate Cancer

Henderson A, Langley SEM, Laing RW.
A Prospective Study of PSA Free Survival Following 125Iodine Seed Prostate Brachytherapy – The First Reported UK Data
British Association of Urological Surgeons, Manchester 2003
Abstracted to British Journal of Urology International 2003: 91(supplement 2):103 (p146)

Langley SEM, Henderson A, Laing RW. (Presented by Langley SEM)
The Cytoreductive Efficacy of Goserelin and Bicalutamide Prior to Radiotherapy
Innovators in Urology – Amsterdam 2003
Abstracted to Prostate Cancer and Prostatic Diseases 2003: 6(supplement 6) S19-28

Langley SEM, Curtis P, Smith JG
Ethical issues in cord blood banking
ISPOG Edinburgh 2004
Abstracted to J Psych Ob Gynae 2004: 25(1) 24

Smith JG, Langley SEM
Umbilical cord stem cells-clinical utility: the present and future
ISPOG Edinburgh 2004
Abstracted to J Psych Ob Gynae 2004: 25(1) 24

Sooriakumaran P, Henderson A, Langley SEM, Laing RW.
125-Iodine prostate brachytherapy and erectile dysfunction- prospective UK data
Joint Brachytherapy Meeting of Groupe Europeen de Curietherapie (GEC), European Society for Therapeutic Radiation Oncology (ESTRO), American Brachytherapy Society (ABS) & Grupo Latino Americano de Curieterapia (GLAC)
Barcelona 2004 (Podium)

Sooriakumaran P, Henderson A, Langley SEM, Laing RW.
PSA results after iodine seed prostate brachytherapy in the UK with up to five years follow up
Joint Brachytherapy Meeting of GEC, ESTRO, ABS & GLAC
Barcelona 2004 (Poster Review)

Sooriakumaran P, Kaba R, Andrews HO, Buchholz NPN.
How & Why Do Flexible Ureteroscopes Break- An Audit of a Major Manufacturer
EAU
Vienna 2004 (Podium)

Sooriakumaran P, Henderson A, Langley SEM, Laing RW, Denham P.
Gleason grading varies among pathologists and this affects treatment strategies in prostate cancer
UK & Ireland Prostate Brachytherapy
Dublin 2004 (Podium)

Sooriakumaran P, Henderson A, Langley SEM, Laing RW.
Erectile dysfunction and its impact on quality of life after 125-iodine prostate brachytherapy
UK & Ireland Prostate Brachytherapy
Dublin 2004 (Podium)

Smith JG, Langley SEM
Umbilical cord stem cells: biological aspects
ISPOG Edinburgh 2004
Abstracted to J Psych Ob Gynae 2004: 25(1) 23

Sooriakumaran P, Henderson A, Langley SEM, Laing RW.
Prostate brachytherapy: PSA results with up to five years follow up
European Society of Therapeutic Radiation Oncologists (ESTRO)
Amsterdam 2004 (Poster Review)

Sooriakumaran P, Henderson A, Langley SEM, Laing RW.
PSA results after five years of prostate brachytherapy
British Oncological Association (BOA)- BOA Prize Proferred Papers Section
Edinburgh 2004 (Podium)

Sooriakumaran P, Henderson A, Langley SEM, Laing RW.
Discrepancies in Gleason scoring affect clinical risk in patients with prostate cancer
BOA
Edinburgh 2004 (Poster)

Sooriakumaran P, Henderson A, Laing RW, Langley SEM.
PSA results after iodine seed prostate brachytherapy- UK data with up to five years follow up
British Association of Urological Surgeons (BAUS)
Harrogate 2004 (Podium)

Sooriakumaran P, Khaksar S, Henderson A, Laing RW, Langley SEM.
Can Europe reproduce the brachytherapy results of the USA?
European Association of Urology (EAU)
Istanbul 2005 (Moderated Poster)

Sooriakumaran P, Henderson A, Khaksar S, Langley SEM, Laing RW.
Effects of brachytherapy on erectile function- prospective UK data.
European Association of Urology (EAU)
Istanbul 2005 (Moderated Poster)

'Measurement of calcium ion concentration in urine with ion-selective electrodes.'
The Physiology Society, Glasgow. July 1990.

'The direct measurement of free urinary calcium in the investigation of urolithiasis.'
Medical Research Society, London. December 1990.

'The direct measurement of free urinary calcium in the investigations of urolithiasis.'
Guy's Urological Research Meeting, Guy's Hospital. January 1991.

Demonstration entitled 'Measurement of the ionic composition of urine with ion-selective electrodes.'
The Physiology Society, Royal Free Hospital, London. February 1991.

'Free Ca2+ - A determinant of urinary tract stone formation.'
The British Association of Urological Surgeons, Glasgow. June 1991.

'Factors influencing the free Ca2+ in urine from normal subjects and from patients with urinary tract stones.'
The Physiology Society, St Thomas' Hospital. November 1991.

'The relationship between urinary Ca2+, pH and stone disease.'
Symposium on Urolithiasis, Cairns, Australia. September 1992.

'A new method for measuring the calcium ion concentration directly in whole urine.'
The American Association of Urologists, San Antonio, USA. May 1993.
Awarded 'Best presentation in section' by AUA

'Management of acute retention: A more efficient service.'
The British Association of Urological Surgeons, Brighton. June 1995.

'Elective vs emergency surgery for patients presenting in acute urinary retention.'
Wessex Urological Group, Gosport. November 1995. Awarded 'Best presentation'

'KTP laser bladder neck incision, BNI, with Nd:YAG ablation of the prostate reduces post-operative catheterization time.'
The American Association of Urologists, Orlando, USA. May 1996.

'Bladder neck incision with KTP and Nd:YAG ablation of the prostate improves clinical outcome and reduces post-operative catheterization time.'
SPIE Meeting, San Jose, USA, February 1996

'KTP laser bladder neck incision with Nd:YAG ablation of the prostate reduces post-operative catheterization time and improves outcome.'
The American Association of Urologists, New Orleans, USA. April 1997.

'Prostate brachytherapy: Patient assessment and symptomatic response'
The British Association of Urological Surgeons, Dublin. June 2001.

'Prostate brachytherapy: A prospective analysis of urological symptoms'
The British Association of Oncologists, Leeds. June 2001

‘A spanner in the works, the use of stents after brachytherapy’
Third International Symposium on Urological Stents, Glasgow, September 2001

‘Antiandrogens in brachytherapy : Not all are equal’
Henderson A, Laing RW, Langley SEM.
Urological Research Society, Royal College of Surgeons of England – January 2002

‘Prostate Brachytherapy; lessons from our first 100 patients’
Henderson A, Cahill D, Laing RW, Langley SEML
Innovations in Urology, Miami 2002

‘Quality of life following treatment for early prostate cancer’
Henderson A, Laing RW, Langley SEM.
Brachytherapy Advanced User’s Group-York 2002

‘Early Outcome from Iodine125 prostate brachytherapy: The Guildford experience’ Henderson A, Laing RW, Langley SEM.
British Prostate Group Spring Meeting-Queens College Cambridge 2002

‘Iodine125 prostate brachytherapy: selection strategies and early clinical and biochemical outcomes, a prospective study’
Henderson A, Laing RW, Langley SEM.
South Thames Regional Urology Meeting 2002
Winning Derek Packham Medal and Prize

‘A prospective comparison of cancer detection using TRUS guided prostate biopsy between consultant urologist, specialist registrar and nurse specialist in oncology’
Henderson A, Andrich DEA, Pietrasik ME, Langley SEM
South West Thames Regional Urology Tumor Group Meeting 2003.

‘Brachytherapy Results and case selection: Update’
Henderson A, Laing RW, Langley SEM.
South West Thames Regional Urology Tumor Group Meeting 2003.

‘A prospective study of PSA free survival following 125Iodine seed prostate brachytherapy- UK data with up to 55 months follow up’
Henderson A, Sooriakumaran P, Laing R.W. Langley S.E.M
South West Thames Regional Urology Meeting, 2003.

‘Systematic saturation prostatic biopsy using a brachytherapy template – The technique and results’
Bott S, Henderson A, Sooriakumaran P, Kooiman G, Langley SEM
South West Thames Regional Urology Tumour Group Meeting Guys Hospital 2003
Awarded prize for best paper

‘A prospective comparison of cancer detection using TRUS guided prostate biopsy between consultant urologist, specialist registrar and nurse specialist in oncology’ Henderson A, Andrich DE, PietrasikME, Sooikumaran P, Higgins D, Montgomery BS & Langley SEM
South West Thames Regional Urology Tumour Group Meeting Guys Hospital.2003

‘Prostate brachytherapy – UK data with up to five years follow up’
Sooriakumaran P, Henderson A, Laing RW, Langley SEM
British Prostate Group London 2004

‘The subjective nature of Gleason scoring affects treatment strategies in prostate cancer’
Sooriakumaran P, Henderson A, Denham P, Laing RW, Langley SEML
British Prostate Group London 2004

‘The impact of erectile dysfunction after 125-iodine prostate brachytherapy’
Sooriakumaran P, Henderson A, Laing RW, Langley SEM. (Presented by PS)
British Prostate Group London 2004

‘Gleason grading varies among pathologists and this affects treatment strategies in prostate cancer’
Sooriakumaran P, Henderson A, Denham P, Langley SEM, Laing RW. UK & Ireland Prostate Brachytherapy Dublin 2004

‘Erectile dysfunction and its impact on quality of life after 125-iodine prostate brachytherapy’
Sooriakumaran P, Henderson A, Langley SEM, Laing RW
UK & Ireland Prostate Brachytherapy Dublin 2004

‘Is penile bulb dose critical in radiation induced impotence?’
Hawkins M, Sooriakumaran P, Henderson A, Ismail A, Langley SEM, Laing RW.
UK & Ireland Prostate Brachytherapy Dublin 2004

‘Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer’
Sooriakumaran P, Henderson A, Langley SEM, Laing RW, Denham P
Clinico-Pathology Meeting, Section of Urology, Royal Society of Medicine 2004. Winner of the AstraZeneca Travelling Fellowship.

Laing,RW, Langley SEM, Salem N,. Kataja V, Nava L, Guedea F. Biochemical outcomes from > 1000 patients treated with I125 prostate brachytherapy. AEuropean collaborative database, ESTRO Amsterdam, 2004

Henderson A, Sooriakumaran P, Laing RW, Langley SEM.
125-Iodine prostate brachytherapy & erectile dysfunction- prospective UK data
GEC ESTRO Barcelona 2004

'The measurement of ionized calcium in urine and other bodily fluids.'
The Gordon Research Conference on Calcium Oxalate, Plymouth, USA. June 1993.

'Manufacture and uses of dip-cast Ca2+-selective electrodes in the measurement of urinary calcium'
The Rock Society, Birmingham, Alabama, USA. January 1994.

'Urolithiasis pathogenesis; the influence of urinary pH'
MSc Course, Institute of Urology & Nephrology, London. March 1995.

'The T pouch: A new orthotopic bladder'
Bladder Cancer Symposium, St George's Hospital, London. May 1997.

'Techniques of orthotopic reconstruction from North America'
Bladder Cancer Symposium, Bristol Royal Infirmary, Bristol. November 1997.

'The role of Prostate Brachytherapy in the management of prostate cancer'
Portugal Urological Association, Coinbour, Portugal June 1999.

'The development of Prostate Brachytherapy in the treatment of prostate cancer.'
Annual Scientific Meeting, Bristol, November 1999

'Prostate Brachytherapy, the Urologist’s perspective'
Brachytherapy Course, Cookridge, Leeds, February 2000

'Prostate Brachytherapy versus Conformal Beam Radiotherapy for the treatment of prostate cancer: A debate.'
European Association of Urology, Annual Meeting, Brussels, Belgium, April 2000

'The role of Prostate Brachytherapy'
Annual Scientific Meeting, Bath, June 2000.

'Prostate Brachytherapy'
Symposium talk, BAUS, Birmingham, June 2000.

‘Patient selection for Prostate Brachytherapy’
4th Advanced Brachytherapy Meeting, Seattle, USA, April 2002.

‘Update on Prostate Brachytherapy’
3rd Southern Prostate Alliance Meeting, Maidstone, Kent, March 2003

‘The Role of Prostate Brachytherapy’
BUAS Annual meeting, Manchester, June 2003

Brachytherapy for Prostatic Carcinoma
EAU Lecture at Belgium Annual Urological Meeting, Essene, Belgium, September 2003

State of the Art Lecture ‘Prostate Brachytherapy’
Royal Society of Medicine, London February 2004

Prostate Brachytherapy
EAU symposium, Vienna, Austria. March 2004

State of the Art Lecture ‘Prostate Brachytherapy’
North Asian Urological Congress, Delhi India, October 2004

Nerve sparing radical prostatectomy
Langley SEM, Lieskovsky G & Skinner DG. Prepared for AUA 1998 meeting.

A new orthotopic bladder - The T pouch
Langley SEM & Skinner DG. Prepared for AUA 1998 meeting.

A patients guide to brachytherapy
Langley SEM & Laing RW 2001 re-filmed and edited 2004

Treatment options in Early Prostate Cancer
Langley SEM & Kirby RS, for national distribution to all GPs and Urologists, 2004